News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
830,647 Results
Type
Article (85557)
Company Profile (696)
Press Release (744394)
Section
Business (232226)
Career Advice (4103)
Deals (39643)
Drug Delivery (115)
Drug Development (90630)
Employer Resources (194)
FDA (17975)
Job Trends (17270)
News (395523)
Policy (39613)
Tag
Academia (2975)
Alliances (56431)
Alzheimer's disease (1331)
Approvals (17875)
Artificial intelligence (150)
Bankruptcy (394)
Best Places to Work (12505)
Biotechnology (480)
Breast cancer (126)
Cancer (1105)
Career advice (3510)
Cell therapy (248)
Clinical research (71374)
Collaboration (389)
Compensation (194)
COVID-19 (2796)
C-suite (96)
Data (1045)
Diabetes (163)
Diagnostics (6667)
Drug pricing (98)
Earnings (94645)
Employer resources (167)
Events (126607)
Executive appointments (291)
FDA (18492)
Funding (344)
Gene therapy (189)
GLP-1 (685)
Government (5041)
Healthcare (20708)
Infectious disease (2884)
Inflammatory bowel disease (118)
Interviews (807)
IPO (17575)
Job creations (5178)
Job search strategy (2854)
Layoffs (488)
Legal (10040)
Lung cancer (178)
Manufacturing (192)
Medical device (14402)
Medtech (14407)
Mergers & acquisitions (22088)
Metabolic disorders (452)
Neuroscience (1616)
NextGen Class of 2024 (7644)
Non-profit (5062)
Northern California (1435)
Obesity (260)
Opinion (243)
Patents (107)
People (64101)
Pharmaceutical (137)
Phase I (21964)
Phase II (30994)
Phase III (23370)
Pipeline (415)
Postmarket research (3539)
Preclinical (9929)
Radiopharmaceuticals (256)
Rare diseases (222)
Real estate (7371)
Regulatory (25917)
Research institute (2640)
Resumes & cover letters (648)
Southern California (1286)
Startups (4274)
United States (13946)
Vaccines (648)
Weight loss (212)
Date
Today (204)
Last 7 days (1012)
Last 30 days (3824)
Last 365 days (38105)
2024 (34315)
2023 (42566)
2022 (53928)
2021 (58726)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Arizona (226)
Asia (49293)
Australia (8687)
California (3350)
Canada (1259)
China (247)
Colorado (150)
Connecticut (155)
Europe (112890)
Florida (447)
Georgia (122)
Illinois (407)
Indiana (207)
Kansas (103)
Maryland (611)
Massachusetts (2739)
Michigan (167)
Minnesota (289)
New Jersey (957)
New York (955)
North Carolina (821)
Northern California (1435)
Ohio (141)
Pennsylvania (828)
South America (1647)
Southern California (1286)
Texas (464)
Washington State (385)
830,647 Results for "cn bio innovations formerly known as zyomyx inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Harmony Biosciences Acquires Epygenix Therapeutics, Inc., Adding Late-Stage Epilepsy Franchise to Growing Pipeline of Innovative CNS Assets
Harmony Biosciences, announced the acquisition of Epygenix Therapeutics, Inc., accelerating its growth strategy by adding a rare epilepsy franchise to its expanding late-stage pipeline of innovative CNS assets.
April 30, 2024
·
9 min read
Genetown
CN Bio Raises $21 Million USD in First Close of Series B Investment Round
CN Bio, a leading provider of single- and multi-organ microphysiological systems, announced it has raised a $21 million investment in the first close of its Series B fundraising round.
April 23, 2024
·
4 min read
Press Releases
Bionomics to Present at the 2024 CNS Summit
November 8, 2024
·
3 min read
BioMidwest
Vanqua Bio to Present at the Stifel 2024 CNS Days Conference
Vanqua Bio announced today that the company will participate in the Stifel 2024 CNS Days Conference, which is being held virtually March 19-20.
March 13, 2024
·
1 min read
Press Releases
Tsingke Successfully Showcases Innovations at BIO-Europe 2024
November 12, 2024
·
3 min read
Drug Development
89bio Initiates Phase 3 ENLIGHTEN-Fibrosis Trial of Pegozafermin in Non-Cirrhotic Metabolic Dysfunction-Associated Steatohepatitis (MASH) Patients with Fibrosis
89bio, Inc. today announced the initiation of its Phase 3 ENLIGHTEN Program evaluating the efficacy and safety of pegozafermin in patients with metabolic dysfunction-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH).
March 12, 2024
·
8 min read
Bio NC
CN Bio and Altis Biosystems Partner to Develop Next-generation Human Gut/Liver in vitro model for Advanced ADME Studies
CN Bio and Altis Biosystems, Inc., leading developers of in vitro human organ models that optimize the accuracy and efficiency of drug development, announced a strategic partnership.
January 23, 2024
·
3 min read
Press Releases
Mercury Bio Appoints Biotech Innovator Alex Koglin, Ph.D. to Board of Directors
With the addition of NTx’s co-founder and former President to the board Mercury Bio significantly enhances its strategic reach in the biotech sector
October 1, 2024
·
2 min read
Press Releases
Merck Completes Acquisition of Investigational B-Cell Depletion Therapy, CN201, from Curon Biopharmaceutical
October 1, 2024
·
4 min read
Pharm Country
Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast to Discuss Parkinson’s Disease Data
Annovis Bio Inc. today announced that it will host an investor webcast to discuss recent developments and future plans for its lead drug candidate, Buntanetap.
June 25, 2024
·
2 min read
1 of 83,065
Next
